-
Mashup Score: 48Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future - 3 day(s) ago
Diabetes Therapy – Cardiovascular, kidney and metabolic (CKM) conditions are interrelated, significantly contributing to morbidity, mortality and healthcare burden. Despite therapeutic advances,…
Source: link.springer.comCategories: General Medicine NewsTweet
-
Mashup Score: 6Experts Suggest NHS Heart Risk Checks From Age 25 - 3 day(s) ago
Starting NHS heart health assessments at 25, not 40, could help tackle soaring lifetime cardiovascular risk and reduce preventable early deaths.
Source: www.medscape.comCategories: General Medicine NewsTweet-
Preventing cardiovascular disease makes both moral and economic sense https://t.co/MnsLtEfh6j
-
-
Mashup Score: 8
Experience the gripping tale of survival and the chain of survival in cardiac arrest. Follow Malcolm Robinson’s harrowing journey in this powerful documentary.
Source: suddencardiacarrestuk.orgCategories: General Medicine NewsTweet-
This is why we should be teaching CPR to everyone https://t.co/bM2wb8YkHR
-
-
Mashup Score: 12GLP-1 Receptor Agonists May Modestly Reduce Risk of Fourteen Obesity-Related Cancers for People with Diabetes - ASCO - 15 day(s) ago
“This trial raises an intriguing hypothesis: that the increasingly popular GLP-1 medications used to treat diabetes and obesity might offer some benefit in reducing the risk of developing cancer. I see many patients with obesity, and given the clear link between cancer and obesity, defining the clinical role of GLP-1 medications in cancer prevention is important. Though this trial does not establish causation, it hints that these drugs might have a preventative effect. Future research is needed to
Source: www.asco.orgCategories: General Medicine NewsTweet-
GLP-1 Receptor Agonists May Modestly Reduce Risk of Fourteen Obesity-Related Cancers for People with Diabetes https://t.co/zsC4e5PxkE https://t.co/dR5glWmijq
-
-
Mashup Score: 8
The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ca…
Source: www.nejm.orgCategories: General Medicine NewsTweet-
💥The Soul study of oral semaglutide is in print https://t.co/WXRH0Nhlwv In T2DM&CVD or CKD, or both, the use of oral semaglutide was associated with a significantly lower risk of major adverse cardiovascular events than placebo, without an increase in serious adverse events
-
-
Mashup Score: 4Proximity to Golf Courses and Risk of Parkinson Disease - 17 day(s) ago
This case-control of older US adults examines risk of Parkinson Disease by proximity of residence to a golf course.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
One of my close friends is both historically a phenomenal and enthusiastic golfer but more recently a victim of Parkinson’s disease. This fascinating paper suggests they may be related https://t.co/lMdjLOjlYH
-
-
Mashup Score: 4Clinical Lipidology 2025 - 27 day(s) ago
The 4th World Congress of Clinical Lipidology which will take place in Vienna, Austria from June 27th to 29th, 2025.
Source: lipids2025.orgCategories: General Medicine News, Cardiologists1Tweet-
The 4th WORLD CONGRESS ON CLINICAL LIPIDOLOGY is in just over 1 month https://t.co/ltasORFKZF 27-29 June 2025 INTERCONTINENTAL HOTEL VIENNA https://t.co/kjFRqhT2E1
-
-
Mashup Score: 1Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes - 29 day(s) ago
This randomized clinical trial examines the relative effect of 4 classes of glucose-lowering medications that were randomly added to metformin on cognitive performance in persons with type 2 diabetes of short duration.
Source: jamanetwork.comCategories: General Medicine News, Cardiologists1Tweet-
The choice of second-line glucose-lowering medication class added to metformin is not associated with change in cognitive performance in persons with early T2D. Worse glycemic control is associated with modestly worse cognitive performance https://t.co/de9n3ZXjQv
-
-
Mashup Score: 33Spironolactone vs Amiloride for Resistant Hypertension - 1 month(s) ago
This randomized trial assesses whether amiloride is noninferior to spironolactone in reducing home-measured systolic blood pressure among patients with resistant hypertension.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
I use both 1⃣spironolactone or 2⃣amiloride in resistant hypertension looks like they both work ! @PCCS_UK @BritishCardioSo @BIHSociety https://t.co/QR8JPk4sGD
-
-
Mashup Score: 5
This decision analytical model study evaluates the net benefit of nonvitamin K antagonist oral anticoagulants in patients with device-detected subclinical atrial fibrillation.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
Is anticoagulation useful in device detected PAF / High rate episodes ? https://t.co/tIWI0X22jK
-
Well done @drkevinfernando @drpatrickholmes and team Our paper on “Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future” is on line @lcw @CVRMUK https://t.co/m1i1gDfdyv https://t.co/s6FpqdPdtk